| 2024-10-14 | Class updated from VUS4 to likely pathogenic/likely CF |
Variant NM_000492.4:c.3131A>G
| Name | NM_000492.4:c.3131A>G |
| Protein name | NP_000483.3:p.(Glu1044Gly) |
| Genomic name (hg19) | chr7:g.117250715A>G UCSC |
| Genomic name (hg38) | chr7:g.117610661A>G UCSC |
| #Exon/intron | exon 19 |
| Legacy Name | E1044G |
| Class | likely pathogenic |
| Subclass | likely CF |
| WT sequence | ACCTCACAGCAACTCAAACAACTGG A ATCTGAAGGTATGACAGTGAATGTG |
| Mutant sequence | ACCTCACAGCAACTCAAACAACTGG G ATCTGAAGGTATGACAGTGAATGTG |
![]() |
![]() | dbSNP rs397508501 |
![]() | ![]() |
| Reference | PMID | Modulator | in vitro / ex vivo data | Clinical data | Variant responsiveness |
| Burgel et al., 2024 | 39151434 | ELX-TEZ-IVA | N.D. | yes | yes |
variant responsiveness based on clinical data, sweat chloride concentration, ppFEV1, chest CT imaging before and after ETI treatment (n=1 patient for 6-8 weeks)
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 2 |
|---|---|
| CF | 2 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CF | 6021 | heterozygote | CF-causing - Trans |
| CF | 730 | homozygote | c.3131A>G - p.(Glu1044Gly) - Trans |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|